Open access · OA
via Europe PMC
Long-Term Post-Mitotic Culture of Human Fibroblasts Recapitulates and Accelerates Features of In Vivo Aging and Enables Dynamic Testing of Anti-Aging Compounds.
Traxler L, Karbacher L, Borgogno O, Ozbun T, Champion K, Smaling A, Zhou-Yang L, Herdy JR, Böhnke L, Böckle BC, Gage FH, Mack HID, Defrancesco M, Mertens J.
Aging cell · 2026
Epigenetic alterations
Rapamycin / mTOR inhibition
Metformin
Partial reprogramming (OSK)
Cell culture / in vitro
Human
In vitro
Abstract
Biological aging drives cellular dysfunction and human disease, yet studying human aging dynamics remains challenging due to limited experimental platforms. Here we show that long-term post-mitotic culture of human fibroblasts recapitulates and accelerates features of in vivo aging. Longitudinal paired transcriptomic and epigenetic analyses of four female fibroblast lines revealed that in vitro aging reflects key signatures of in vivo primary fibroblast aging. Direct neuronal conversion of in vitro-aged fibroblasts preserved biological age, enabling pseudo-longitudinal modeling of neuronal aging through direct reprogramming. Single-cell transcriptomics of in vitro-aging fibroblasts revealed a time-dependent increase in age-heterogeneity, consistent with the previously reported age-associated heterogeneity driven by the variable loss of transcriptional programs in vivo. Using this accelerated aging platform, we evaluated anti-aging compounds: Metformin broadly attenuated transcriptomic and epigenetic aging, while mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition) showed limited efficacy. These findings align with pre-clinical evidence, providing a platform to evaluate and predict therapeutic anti-aging compound efficacy at molecular resolution. This system advances our understanding of aging mechanisms and facilitates the development of interventions against age-related diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1111/acel.70796
- Canonical
- link ↗
- Fetched
- 2026-11-03 MST
Cite this
APA
L, T., L, K., O, B., T, O., K, C., A, S., L, Z., JR, H., L, B., BC, B., FH, G., HID, M., M, D., & J., M. (2026). Long-Term Post-Mitotic Culture of Human Fibroblasts Recapitulates and Accelerates Features of In Vivo Aging and Enables Dynamic Testing of Anti-Aging Compounds. <em>Aging cell</em>. https://doi.org/10.1111/acel.70796
Vancouver
L T, L K, O B, T O, K C, A S, et al. Long-Term Post-Mitotic Culture of Human Fibroblasts Recapitulates and Accelerates Features of In Vivo Aging and Enables Dynamic Testing of Anti-Aging Compounds. Aging cell. 2026. doi:10.1111/acel.70796.
BibTeX
@article{traxler2026LongTe,
title = {Long-Term Post-Mitotic Culture of Human Fibroblasts Recapitulates and Accelerates Features of In Vivo Aging and Enables Dynamic Testing of Anti-Aging Compounds.},
author = {Traxler L and Karbacher L and Borgogno O and Ozbun T and Champion K and Smaling A and Zhou-Yang L and Herdy JR and Böhnke L and Böckle BC and Gage FH and Mack HID and Defrancesco M and Mertens J.},
journal = {Aging cell},
year = {2026},
doi = {10.1111/acel.70796},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell 2016
Open access · OA
Epigenetic Mechanisms of Longevity and Aging
Methods 2014
Preprint · OA
Studying aging in Drosophila
Genes & diseases 2025
Open access · OA
Obesity accelerates aging: Mechanisms and therapeutic implications
Gut Microbes 2024
Open access · CC-BY
The human gut microbiome and aging
Elsevier eBooks 2017
Citation only
The Epigenetic Clock and Aging
Springer eBooks 2005
Citation only